Skip to content
healthcare.dev

Alahist PE

NDC 50991-788, Dexbrompheniramine Maleate, Phenylephrine Hydrochloride, tablet, from Poly Pharmaceuticals, Inc..

Product NDC
50991-788
Status
Listed
Labeler
Poly Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50991-788 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXBROMPHENIRAMINE MALEATE2 mg/1
  • PHENYLEPHRINE HYDROCHLORIDE7.5 mg/1

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
50991-788-025099107880212 TABLET in 1 BLISTER PACK (50991-788-02)
50991-788-905099107889090 TABLET in 1 BOTTLE (50991-788-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 50991078890

    GET /v1/drugs/nadac/50991078890

Use it

Look up 50991-788 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50991-788 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50991-788. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.